Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland

Evaluation of possibilities in identification and susceptibility testing forCandida glabrataclinical isolates with the Integral System Yeast Plus (ISYP)

(2014) Piotr Szweda et al.   ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Identification of Genomic Binding Sites for Candida glabrata Pdr1 Transcription Factor in Wild-Type and ρ0Cells

(2014) Sanjoy Paul et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis

(2014) C. Costa et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Effect of Amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis Biofilm Formation

(2014) Małgorzata Prażyńska et al.   MYCOPATHOLOGIA

Candida glabrata: a review of its features and resistance

(2013) C. F. Rodrigues et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candidaemia in a Polish tertiary paediatric hospital, 2000 to 2010

(2013) Katarzyna Dzierzanowska-Fangrat et al.   MYCOSES

Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm

(2013) Nicolas Papon et al.   PLoS Pathogens

Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation inERG11and Exhibiting Cross-Resistance to Azoles and Amphotericin B

(2012) Claire M. Hull et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice

(2011) Sélène Ferrari et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutational Analysis of Flucytosine Resistance in Candida glabrata

(2010) T. D. Edlind et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology of Invasive Mycoses in North America

(2010) Michael A. Pfaller et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Epidemiology of invasive candidiasis

(2010) Maiken C Arendrup   Current Opinion in Critical Care

Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature

(2010) Florent Morio et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

(2010) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular analysis of Candida glabrata clinical isolates

(2010) Norbert Berila et al.   MYCOPATHOLOGIA

Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia

(2009) Norbert Berila et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The changing face of epidemiology of invasive fungal disease in Europe

(2009) Cornelia Lass-Flörl   MYCOSES